WHO Drug Information
WHO drug information provides an overview of topics of current relevance relating to drug development and regulation. Latest lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN) are also included.
About WHO Drug Information
WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers.
Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers, consumer bodies, and pharmaceutical manufacturers and focuses on topics impacting the safety, efficacy and quality of medicines, medical products, herbals and biomedicines. It presents a range of perspectives on how current challenges impact the manufacture, prescribing and access of medicines throughout the world and introduces newly-released guidance documents.
For enquiries, please send an e-mail to druginfo@who.int
Information developed by WHO:
Guidelines and recommendations concerning medicines, biologicals, vaccines, medical devices, herbals and related products
Subscription
Subscription information:
WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN).
WHO Drug Information is published 4 times a year.
To subscribe, please send an e-mail to druginfo@who.int
or order from
Latest issue
Featured publication | 13 October 2023
WHO Drug Information - Volume 37, No. 3
The third issue of volume 37 includes:
Consultation Documents and the International Nonproprietary Names (INN) Recommended INN List No. 90
Revisions of the Essential Medicines lists
Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP)
The ECSPP meets annually to discuss latest scientific and technical issues in the quality assurance area.
International Nonproprietary Names (INN)
Information from research institutions, medical journals and regulatory authorities:
- Commentaries on clinical trials of drugs important for regulatory authorities
- Newly reported adverse reactions
- Dangerous drug combinations
- Drug warnings and amendments to product information
- Changes in treatment
- News briefs
- Articles on issues of current concern
Published issues
2023
2022
2021